Pharmaceutical solutions provider AmerisourceBergen Corporation (NYSE: ABC) reported higher revenues and adjusted earnings for the second quarter of 2023.

• Second-quarter revenue increased 10% annually to $63.5 billion, reflecting double-digit growth in revenue within U.S. Healthcare Solutions
• Reported earnings per share were $2.13 in the second quarter, down 18% from $2.59 reported in the previous year’s second quarter
• Gross profit moved up 2.7% year-over-year to $2.3 billion in the second quarter, reflecting higher gross profit in both reportable segments
• In Q2, operating expenses were $1.7 billion, which is up 19.2% compared to the same period in the previous fiscal year
• Reflecting the increase in operating expenses, second-quarter operating income decreased sharply to $560.5 million

The post A snapshot of AmerisourceBergen’s Q2 2023 earnings results first appeared on AlphaStreet.